triumph-1 retatrutide A summary slide of the data presented today by Dr. Ania Jastreboff at #ADA2026 🚨 TRIUMPH-1: Phase 3 Obesity Trial with Retatrutide 🚨 Retatrutide 💉, a once-weekly triple hormone receptor Retatrutide Reduces Body Weight by

All peptide use is screened, prescribed, and monitored by a medical provider

Dynamic change of fungal community in the gastrointestinal tract of growing lambs

The breadth of DSIPs biological activity spanning sleep regulation, stress modulation, pain processing, antioxidant defence, and neuroprotection has led some researchers to characterise it as an adaptogenic peptide: one that supports homeostatic balance across multiple physiological systems rather than acting on a single discrete target

In human plasma GHK is present at about 200 micrograms/litre in men of age 20- 25 but declines to 80 micrograms/litre by age 60-80

At the end of the study period, researchers found that the patients who had received semaglutide not only lost weight: they had a stunning 20% decrease in cardiovascular events, including cardiovascular death, heart attacks, and strokes